Loading clinical trials...
Loading clinical trials...
Prospective Registry for Multimodal Assessment of Neuromuscular Pathology Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
Conditions
Interventions
laboratory biomarkers
muscle ultrasound
Locations
1
Germany
University Hospital Tuebingen
Tübingen, Germany
Start Date
March 20, 2020
Primary Completion Date
March 31, 2021
Completion Date
March 31, 2022
Last Updated
April 29, 2020
NCT07221162
NCT06721949
NCT06082518
NCT06631287
NCT06679140
NCT06417762
Lead Sponsor
University Hospital Tuebingen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions